New grad roles at Kernal Biologics, Inc.
Kernal Bio develops AI-designed mRNA therapeutics delivered by antibody-decorated lipid nanoparticles. Its platform targets specific tissues and cells for in vivo CAR-T treatments for cancer and autoimmune diseases.
- Industry
- Biotech & Pharma, AI & Machine Learning, Healthcare & Health Tech
- Company size
- 11–50 employees
- Stage
- Series A
- Open roles
- 3
No current roles
Check back soon.
Get new Kernal Biologics, Inc. new grad roles by email
Free account. Get new Kernal Biologics, Inc. new grad roles by email or push the minute they post.
